The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
Minimal residual illness, or MRD, testing might have the potential to supply peace of thoughts to survivors of breast most cancers, as a survivor and...
Kidney most cancers administration has seen notable advances over the previous a number of many years, reflecting each improved diagnostic capabilities and...
The U.S. Meals and Drug Administration (FDA) has granted quick observe designation to the investigational remedy MNV-201 for the therapy of myelodysplastic...
The U.S. Meals and Drug Administration (FDA) granted approval to Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) on Sept. 19, 2025, for subcutaneous...
